Home Other Building Blocks Bms-564929

Bms-564929

CAS No.:
627530-84-1
Catalog Number:
AG00ECCY
Molecular Formula:
C14H12ClN3O3
Molecular Weight:
305.7164
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
98%
1 week
United States
$240
- +
10mg
98%
1 week
United States
$357
- +
50mg
98%
1 week
United States
$1257
- +
Product Description
Catalog Number:
AG00ECCY
Chemical Name:
Bms-564929
CAS Number:
627530-84-1
Molecular Formula:
C14H12ClN3O3
Molecular Weight:
305.7164
MDL Number:
MFCD15146692
IUPAC Name:
4-[(7R,7aS)-7-hydroxy-1,3-dioxo-5,6,7,7a-tetrahydropyrrolo[1,2-c]imidazol-2-yl]-2-chloro-3-methylbenzonitrile
InChI:
InChI=1S/C14H12ClN3O3/c1-7-9(3-2-8(6-16)11(7)15)18-13(20)12-10(19)4-5-17(12)14(18)21/h2-3,10,12,19H,4-5H2,1H3/t10-,12+/m1/s1
InChI Key:
KEJORAMIZFOODM-PWSUYJOCSA-N
SMILES:
N#Cc1ccc(c(c1Cl)C)N1C(=O)[C@H]2N(C1=O)CC[C@H]2O
UNII:
9BLW27W4X7
Properties
Complexity:
531  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
2  
Defined Bond Stereocenter Count:
0
Exact Mass:
305.057g/mol
Formal Charge:
0
Heavy Atom Count:
21  
Hydrogen Bond Acceptor Count:
4  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
305.718g/mol
Monoisotopic Mass:
305.057g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
84.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
1.1  
Literature
Title Journal
Nonsteroidal selective androgen receptor modulators (SARMs): dissociating the anabolic and androgenic activities of the androgen receptor for therapeutic benefit. Journal of medicinal chemistry 20090625
N-aryl-oxazolidin-2-imine muscle selective androgen receptor modulators enhance potency through pharmacophore reorientation. Journal of medicinal chemistry 20090514
Synthesis and SAR of tetrahydropyrrolo[1,2-b][1,2,5]thiadiazol-2(3H)-one 1,1-dioxide analogues as highly potent selective androgen receptor modulators. Bioorganic & medicinal chemistry letters 20070815
Tandem optimization of target activity and elimination of mutagenic potential in a potent series of N-aryl bicyclic hydantoin-based selective androgen receptor modulators. Bioorganic & medicinal chemistry letters 20070401
Pharmacological and x-ray structural characterization of a novel selective androgen receptor modulator: potent hyperanabolic stimulation of skeletal muscle with hypostimulation of prostate in rats. Endocrinology 20070101
Properties